Search Ontology:
ChEBI
N-acetyllactosamine
- Term ID
- CHEBI:16153
- Synonyms
-
- 2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-beta-D-glucopyranose
- beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- beta-D-Galactosyl-1,4-N-acetyl-D-glucosamine
- beta-D-glucopyranose, 2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-
- Galb1-4GlcNAcb
- Galbeta1-4GlcNAcbeta
- LacNAc
- N-acetyllactosamine
- WURCS=2.0/2,2,1/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5]/1-2/a4-b1
- Definition
- A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre.
- References
-
- CAS:32181-59-2
- GlyGen:G00055MO
- GlyTouCan:G00055MO
- KEGG:C00611
- KEGG:G00246
- PMID:11181561
- PMID:11429474
- PMID:14631106
- PMID:14672941
- PMID:16966407
- PMID:18280060
- PMID:18849325
- PMID:19443021
- PMID:19486884
- PMID:21496117
- PMID:2457603
- PMID:25568069
- PMID:26802542
- PMID:31537530
- PMID:7706263
- PMID:8737251
- Reaxys:1440779
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- inverse has_functional_parent
Show first 5 Terms
Show All 9 Terms
Phenotype
Phenotype resulting from N-acetyllactosamine
Phenotype where environments contain N-acetyllactosamine
Phenotype modified by environments containing N-acetyllactosamine
Phenotype affecting N-acetyllactosamine
Human Disease Model